165 related articles for article (PubMed ID: 24618151)
21. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Surgical Management of Advanced Stages of Borderline Ovarian Tumours].
Raimond E; Bourdel N
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):304-313. PubMed ID: 32004785
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2009 Apr; 113(1):75-82. PubMed ID: 19171373
[TBL] [Abstract][Full Text] [Related]
23. Identification of factors that impact recurrence in patients with borderline ovarian tumors.
Chen X; Fang C; Zhu T; Zhang P; Yu A; Wang S
J Ovarian Res; 2017 Apr; 10(1):23. PubMed ID: 28376898
[TBL] [Abstract][Full Text] [Related]
24. [Prognosis and fertility outcomes of patients with borderline ovarian tumors after fertility-sparing surgery].
Zhang Y; Wang QN; Huang Z; Chu R; Dong TT; Zhang YZ; Yang XS; Jiang J; Cui BX; Song K; Kong B
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(26):1999-2004. PubMed ID: 35817724
[No Abstract] [Full Text] [Related]
25. Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor.
Romeo M; Pons F; Barretina P; Radua J
World J Surg Oncol; 2013 Jan; 11():13. PubMed ID: 23343188
[TBL] [Abstract][Full Text] [Related]
26. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text].
Bourdel N; Huchon C; Cendos AW; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chéreau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):223-235. PubMed ID: 32004780
[TBL] [Abstract][Full Text] [Related]
27. Borderline ovarian tumors: a retrospective cohort study on single institution experience, practice patterns and outcomes.
Abdallah R; Chamsy D; Dagher C; Hajjar R; El Housheimi A; Seoud M; Khalil A
J Obstet Gynaecol; 2022 Nov; 42(8):3600-3604. PubMed ID: 36250321
[TBL] [Abstract][Full Text] [Related]
28. Recurrence and prognostic factors in borderline ovarian tumors.
Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
[TBL] [Abstract][Full Text] [Related]
29. Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours.
Ouldamer L; Bendifallah S; Naoura I; Body G; Uzan C; Morice P; Ballester M; Daraï E
Hum Reprod; 2016 Aug; 31(8):1732-7. PubMed ID: 27496944
[TBL] [Abstract][Full Text] [Related]
30. A retrospective study of 27 ovarian tumors of low malignant potential.
Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
[TBL] [Abstract][Full Text] [Related]
31. What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.
Candotti G; Peiretti M; Mangili G; Bergamini A; Candiani M; Cioffi R; Mais V; Rabaiotti E; Bocciolone L
Eur J Surg Oncol; 2020 May; 46(5):888-892. PubMed ID: 31722834
[TBL] [Abstract][Full Text] [Related]
32. Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group.
Chevrot A; Pouget N; Bats AS; Huchon C; Guyon F; Chopin N; Rousset-Jablonski C; Beurrier F; Lambaudie E; Provansal M; Sabatier R; Heinemann M; Ngo C; Bonsang-Kitzis H; Lecuru F; Bailly E; Ferron G; Cornou C; Lardin E; Leblanc E; Philip CA; Ray-Coquard I; Hequet D
Gynecol Oncol; 2020 Apr; 157(1):29-35. PubMed ID: 32241341
[TBL] [Abstract][Full Text] [Related]
33. Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group).
Wimberger P; Wehling M; Lehmann N; Kimmig R; Schmalfeldt B; Burges A; Harter P; Pfisterer J; du Bois A
Ann Surg Oncol; 2010 Jun; 17(6):1642-8. PubMed ID: 20165986
[TBL] [Abstract][Full Text] [Related]
34. Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments.
Uzan C; Nikpayam M; Ribassin-Majed L; Gouy S; Bendifallah S; Cortez A; Rey A; Duvillard P; Darai E; Morice P
Ann Oncol; 2014 Jul; 25(7):1312-1319. PubMed ID: 24713312
[TBL] [Abstract][Full Text] [Related]
35. Borderline ovarian tumor in pregnancy: can surgery wait? A case series.
Vidal Urbinati AM; Iacobone AD; Di Pace RC; Pino I; Pittelli MR; Guerrieri ME; Preti EP; Franchi D
Arch Gynecol Obstet; 2021 Dec; 304(6):1561-1568. PubMed ID: 33950305
[TBL] [Abstract][Full Text] [Related]
36. [Clinical and pathological features of borderline ovarian tumors].
Li Y; Cui H; Shen DH; Zhao Y; Wei LH; Qian HN
Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):81-4. PubMed ID: 12783693
[TBL] [Abstract][Full Text] [Related]
37. Improving the clinical management of women with borderline tumours: a recurrence risk scoring system from a French multicentre study.
Ouldamer L; Bendifallah S; Nikpayam M; Body G; Fritel X; Uzan C; Morice P; Daraï E; Ballester M
BJOG; 2017 May; 124(6):937-944. PubMed ID: 28122418
[TBL] [Abstract][Full Text] [Related]
38. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
[TBL] [Abstract][Full Text] [Related]
39. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
Matsuo K; Machida H; Mandelbaum RS; Grubbs BH; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2019 May; 153(2):230-237. PubMed ID: 30797590
[TBL] [Abstract][Full Text] [Related]
40. Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.
Wang L; Zhong Q; Tang Q; Wang H
Arch Gynecol Obstet; 2022 Oct; 306(4):1177-1183. PubMed ID: 35396974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
